Index by author
January 01, 2005; Volume 72,
Frontiers in Inflammatory Joint Diseases Conference
B
Badley, Elizabeth M
- You have accessArthritis in Canada: what do we know and what should we know?Elizabeth M BadleyThe Journal of Rheumatology Supplement January 1 2005, 72 39-41;
E
El-Gabalawy, Hani
- You have accessCommon denominators of inflammatory joint diseases.Hani El-GabalawyThe Journal of Rheumatology Supplement January 1 2005, 72 3-6;
Evans, Christopher H
- You have accessGene therapy: what have we accomplished and where do we go from here?Christopher H EvansThe Journal of Rheumatology Supplement January 1 2005, 72 17-20;
F
Farewell, Vernon T
- You have accessLongitudinal cohort studies.Dafna D Gladman and Vernon T FarewellThe Journal of Rheumatology Supplement January 1 2005, 72 30-32;
Feldman, Brian M
- You have accessTreating children with arthritis: towards an evidence-based culture.Brian M FeldmanThe Journal of Rheumatology Supplement January 1 2005, 72 33-35;
Frank, John W
- You have accessSetting research priorities for arthritis: the environmental perspective.John W FrankThe Journal of Rheumatology Supplement January 1 2005, 72 58-61;
G
Gladman, Dafna D
- You have accessLongitudinal cohort studies.Dafna D Gladman and Vernon T FarewellThe Journal of Rheumatology Supplement January 1 2005, 72 30-32;
H
Haraoui, Boulos
- You have accessThe anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.Boulos HaraouiThe Journal of Rheumatology Supplement January 1 2005, 72 46-47;
Hyrich, Kimme L
- You have accessAssessing the safety of biologic therapies in rheumatoid arthritis: the challenges of study design.Kimme L HyrichThe Journal of Rheumatology Supplement January 1 2005, 72 48-50;
L
Lacaille, Diane
- You have accessArthritis and employment research: where are we? Where do we need to go?Diane LacailleThe Journal of Rheumatology Supplement January 1 2005, 72 42-45;
Lappin, Debra R
- You have accessClinical research and the new public partnership--a view from the South.Debra R LappinThe Journal of Rheumatology Supplement January 1 2005, 72 27-29;
Li, Linda C
- You have accessWhat else can I do but take drugs? The future of research in nonpharmacological treatment in early inflammatory arthritis.Linda C LiThe Journal of Rheumatology Supplement January 1 2005, 72 21-24;
Lipsky, Peter E
- You have accessIntegrating biologic therapy into the comprehensive care of patients with rheumatoid arthritis.Peter E LipskyThe Journal of Rheumatology Supplement January 1 2005, 72 54-57;
M
Maetzel, Andreas
- You have accessCost-effectiveness estimates reported for tumor necrosis factor blocking agents in rheumatoid arthritis refractory to methotrexate--a brief summary.Andreas MaetzelThe Journal of Rheumatology Supplement January 1 2005, 72 51-53;
O
O'Dell, James
- You have accessRheumatoid arthritis initial therapy: unanswered questions.James O'DellThe Journal of Rheumatology Supplement January 1 2005, 72 14-16;
R
Reveille, John D
- You have accessGenetic studies in the rheumatic diseases: present status and implications for the future.John D ReveilleThe Journal of Rheumatology Supplement January 1 2005, 72 10-13;
T
Tak, Paul P
- You have accessAnalyzing synovial tissue samples. What can we learn about early rheumatoid arthritis, the heterogeneity of the disease, and the effects of treatment?Paul P TakThe Journal of Rheumatology Supplement January 1 2005, 72 25-26;
V
van den Berg, Wim B
- You have accessAnimal models of arthritis. What have we learned?Wim B van den BergThe Journal of Rheumatology Supplement January 1 2005, 72 7-9;
Y
Yelin, Edward
- You have accessIs early intervention worth it?Edward YelinThe Journal of Rheumatology Supplement January 1 2005, 72 36-38;